← Back to Search

Behavioral Intervention

Educational Intervention for HPV Vaccine Uptake

N/A

Waitlist Available

Led By Evelinn Borrayo

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be a Denver Health patient* 18-26 years old, who has not started or completed the HPV vaccine series (Vaccine completion for this age group is 3 doses).

Be a parent of a Denver Health adolescent patient* aged 9-17 years old, who has not started or completed the HPV vaccine series. (Vaccine completion is 2 doses for 9-14-year-old, and 3 doses for 14-17-year old)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3, 6, 9 and 12 months post intervention

Awards & highlights

Study Summary

This trial will test whether providing educational materials about HPV and the HPV vaccine to CHEs will increase CHE HPV-related cancer knowledge and confidence to deliver cancer prevention messages to their community.

Who is the study for?

This trial is for parents of Denver Health patients aged 9-17 who haven't started or completed the HPV vaccine series, and Denver Health patients themselves aged 18-26 in the same situation. Participants must speak English or Spanish and be willing to follow study procedures.Check my eligibility

What is being tested?

The trial tests an educational program about HPV and its vaccine, using NCI toolkit materials like presentations, flyers, posters, plus a video developed by researchers. It aims to increase awareness and vaccination rates among eligible adolescents and young adults.See study design

What are the potential side effects?

Since this is an educational intervention rather than a medical treatment, there are no direct side effects from medication. However, participants may experience discomfort with the subject matter or time commitment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18-26 years old, a Denver Health patient, and have not completed the HPV vaccine series.

Select...

I am a parent of a child aged 9-17 who hasn't completed their HPV vaccine series.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3, 6, 9 and 12 months post intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3, 6, 9 and 12 months post intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, 9 and 12 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Sociodemographic data (e.g., age, gender, ethnicity, insurance, income, zip code) as it relates to vaccine uptake

The change in parents & young adults' knowledge & intentions to obtain the HPV vaccine

Secondary outcome measures

Uptake of one, two, or three HPV vaccine doses among adolescents (9 to 17 years old) and young adults (18-26 years old).

Other outcome measures

Intervention's delivery and patient-level & system-level impact.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Patients Eligible for HPV VaccineExperimental Treatment1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,932,781 Total Patients Enrolled

University of Colorado, DenverLead Sponsor

1,732 Previous Clinical Trials

2,143,176 Total Patients Enrolled

Evelinn BorrayoPrincipal InvestigatorUniversity of Colorado, Denver

Media Library

HPV Educational Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04611022 — N/A

Human Papillomavirus Research Study Groups: Patients Eligible for HPV Vaccine

Human Papillomavirus Clinical Trial 2023: HPV Educational Intervention Highlights & Side Effects. Trial Name: NCT04611022 — N/A

HPV Educational Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04611022 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this venture actively recruiting participants?

"Clinicaltrials.gov reveals that this medical study, which began on August 28th 2020 and was most recently updated June 7th 2022, is no longer enrolling patients. However, there are 89 other clinical trials currently recruiting participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine

2020. "Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04611022.

All > Hpv